A therapeutic strategy uses histone deacetylase inhibitors to modulate the expression of genes involved in the pathogenesis of rheumatoid arthritis

Author： Chung Y.-L.   Lee M.-Y.   Wang A.-J.   Yao L.-F.  

Publisher： Elsevier

ISSN： 1525-0016

Source： Molecular Therapy, Vol.8, Iss.5, 2003-11, pp. : 707-717

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Emerging Therapeutic Strategies for Rheumatoid Arthritis

By  

Current Drug Therapy, Vol. 7, Iss. 3, 2012-09 ,pp. : 198-206

Bentham Science Publishers

Access to resources Recommend Favorite

The Plasticity of Th17 Cells in the Pathogenesis of Rheumatoid Arthritis

By Kotake Shigeru   Yago Toru   Kobashigawa Tsuyoshi   Nanke Yuki  

Journal of Clinical Medicine, Vol. 6, Iss. 7, 2017-07 ,pp. : 67-67

MDPI

Access to resources Recommend Favorite

How Does Leflunomide Modulate the Immune Response in Rheumatoid Arthritis?

By Fox R.I.  

BioDrugs, Vol. 12, Iss. 4, 1999-10 ,pp. : 301-315

Adis International

Access to resources Recommend Favorite

T-Cell-Activation Inhibitors in Rheumatoid Arthritis

By Lorenz H-M.  

BioDrugs, Vol. 17, Iss. 4, 2003-01 ,pp. : 263-270

Adis International

Access to resources Recommend Favorite

New Therapeutic Approaches to the Management of Rheumatoid Arthritis

By Hughes L.B.   Moreland L.W.  

BioDrugs, Vol. 15, Iss. 6, 2001-06 ,pp. : 379-393

Adis International

Access to resources Recommend Favorite